UK markets closed

Cyteir Therapeutics, Inc. (CYTT)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
3.0100-0.0100 (-0.33%)
At close: 03:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-33,215
-46,061
-42,126
-20,823
-15,044
Depreciation & amortisation
538
668
479
351
215
Stock-based compensation
3,286
4,682
3,465
467
247
Change in working capital
2,681
-2,528
2,150
1,466
-2,160
Accounts payable
-1,158
-657
38
1,027
-884
Other working capital
-25,789
-42,844
-37,221
-19,389
-17,690
Other non-cash items
-4
707
-
-
-815
Net cash provided by operating activities
-25,789
-42,532
-36,032
-18,539
-17,557
Cash flows from investing activities
Investments in property, plant and equipment
-
-312
-1,189
-850
-133
Net cash used for investing activities
303
-312
-1,189
-850
-133
Cash flows from financing activities
Common stock issued
-
0
136,120
0
-
Net cash used provided by (used for) financing activities
842
242
216,006
1,427
36,890
Net change in cash
-24,644
-42,602
178,785
-17,962
19,200
Cash at beginning of period
154,147
189,979
11,194
29,156
9,956
Cash at end of period
129,503
147,377
189,979
11,194
29,156
Free cash flow
Operating cash flow
-25,789
-42,532
-36,032
-18,539
-17,557
Capital expenditure
-
-312
-1,189
-850
-133
Free cash flow
-25,789
-42,844
-37,221
-19,389
-17,690